NCT06661252Completed
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 111 (actual)
- First submitted
- 22 Oct 2024
- Start date
- 8 Jan 2025
- Primary completion date
- 25 Nov 2025
- Lead sponsor
- Diag-Nose Medical Pty Ltd
- NCT number
- NCT06661252
What you commit to
- Study type: Observational
- Participants enrolled: 111
- From 8 Jan 2025 to the primary completion date, 25 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior history of adverse reaction or contraindicated to diagnostic testing including fingerprick blood sampling, pulmonary testing, nasal swab/sampling.
Other illness
- Any other conditions limiting the volunteer's ability to complete study requirements in the judgement of the investigator/clinician
- History of nasal surgery or trauma within the last 3 months
Age
- Less than 18 years of age at the time of enrolment.
Other
- Volunteers who are actively pregnant
- Any nasal anatomical issue or finding which may limit the safe insertion of the ABEL collection device, as determined by investigator/clinician
Who the study is looking for
- All participants:
- 18 years of age or older
- The participant must be able to comprehend and sign an approved Informed Consent Form and other applicable study documents.
- Healthy volunteers:
- No significant sinonasal/pulmonary symptoms or prior diagnoses of sinonasal/pulmonary conditions as determined by pre-enrolment questionnaires.
- Case goup:
- Participants must be previously diagnosed with rhinitis, chronic sinusitis, asthma, or COPD by a medical professional.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Diag-Nose Medical Coordinator of this site? Confirm its status | Notting Hill | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.